{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:27:08Z","timestamp":1783560428514,"version":"3.55.0"},"reference-count":97,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T00:00:00Z","timestamp":1254182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000515","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T22:40:12Z","timestamp":1254177612000},"page":"e515","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Novel Vaccines to Human Rabies"],"prefix":"10.1371","volume":"3","author":[{"given":"Hildegund C. J.","family":"Ertl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,9,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.","volume":"84","author":"CL Schumacher","year":"1989","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0264-410X(91)90188-C","article-title":"The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines.","volume":"9","author":"PS Wunderli","year":"1991","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/viro.1995.0049","article-title":"Immune effector mechanisms required for protection to rabies virus.","volume":"214","author":"ZQ Xiang","year":"1995","journal-title":"Virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0092-1157(89)90018-8","article-title":"Effect of strain differences on the potency testing of rabies vaccines in mice.","volume":"17","author":"J Blancou","year":"1989","journal-title":"J Biol Stand"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jama.1973.03230100043011","article-title":"Airborne rabies transmission in a laboratory worker.","volume":"226","author":"WG Winkler","year":"1973","journal-title":"Jama"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma.","volume":"352","author":"RE, Willoughby Jr.","year":"2005","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11908-009-0044-0","article-title":"Update on rabies diagnosis and treatment.","volume":"11","author":"AC Jackson","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.279.6.421","article-title":"(1998) From the Centers for Disease Control and Prevention. Human rabies\u2013Texas and New Jersey, 1997.","volume":"279","year":"1998","journal-title":"Jama"},{"key":"ref9","first-page":"95","article-title":"(1999) Human rabies\u2013Virginia, 1998.","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey.","volume":"11","author":"MK Sudarshan","year":"2007","journal-title":"Int J Infect Dis"},{"key":"ref11","article-title":"Rabies in China: An Update.","author":"R Hu","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1016\/j.vaccine.2008.04.087","article-title":"Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB).","volume":"26","author":"B Dodet","year":"2008","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/344905","article-title":"Management of rabies in humans.","volume":"36","author":"AC Jackson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref14","first-page":"137","article-title":"Stray dogs in Bangkok, Thailand: rabies virus infection and rabies antibody prevalence.","volume":"131","author":"S Kasempimolporn","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"ref15","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008: recommendations of the Advisory Committee on Immunization Practices.","volume":"57","author":"SE Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"ref16","first-page":"425","article-title":"(2007) Rabies vaccines. WHO position paper.","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.","volume":"26","author":"AB Bakker","year":"2008","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jchromb.2008.10.030","article-title":"Chromatographic purification of equine immunoglobulin G F(ab)2 from plasma.","volume":"876","author":"A Fernandes","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0264-410X(02)00585-6","article-title":"The challenge to provide affordable rabies post-exposure treatment.","volume":"21","author":"MJ Warrell","year":"2003","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1531-8249(199905)45:5<595::AID-ANA7>3.0.CO;2-M","article-title":"Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis.","volume":"45","author":"S Piyasirisilp","year":"1999","journal-title":"Ann Neurol"},{"key":"ref21","first-page":"27","article-title":"Epidemiology of animal bites and rabies cases in India. A multicentric study.","volume":"40","author":"RL Ichhpujani","year":"2008","journal-title":"J Commun Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1503\/cmaj.071488","article-title":"Rabies in India.","volume":"178","author":"R Menezes","year":"2008","journal-title":"Cmaj"},{"key":"ref23","first-page":"1","article-title":"(2005) WHO Expert Consultation on rabies.","volume":"931","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.","volume":"81","author":"TJ Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1994.1105","article-title":"Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.","volume":"199","author":"ZQ Xiang","year":"1994","journal-title":"Virology"},{"key":"ref26","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries.","volume":"119","author":"F Cliquet","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"ref27","first-page":"461","article-title":"Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs.","volume":"131","author":"D Bankovskiy","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1982.180.11.1336","article-title":"Vaccine-induced rabies in four cats.","volume":"180","author":"JB Esh","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.","volume":"80","author":"B Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1128\/JVI.75.19.9121-9128.2001","article-title":"Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.","volume":"75","author":"N Ito","year":"2001","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.","volume":"79","author":"M Faber","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2005.03.011","article-title":"Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity.","volume":"111","author":"K Morimoto","year":"2005","journal-title":"Virus Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1348-0421.2005.tb03692.x","article-title":"Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain.","volume":"49","author":"N Ito","year":"2005","journal-title":"Microbiol Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.","volume":"26","author":"J Cenna","year":"2008","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0905640106","article-title":"Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.","volume":"106","author":"M Faber","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines.","volume":"82","author":"EB Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/BC.2008.054","article-title":"Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.","volume":"389","author":"S Benko","year":"2008","journal-title":"Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.vaccine.2008.01.043","article-title":"A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine.","volume":"26","author":"X Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development.","volume":"30","author":"SG Reed","year":"2009","journal-title":"Trends Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10875-007-9087-x","article-title":"Toll or toll-free adjuvant path toward the optimal vaccine development.","volume":"27","author":"KJ Ishii","year":"2007","journal-title":"J Clin Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00144826","article-title":"The use of immunosome technology for vaccines against rabies and other viral diseases.","volume":"5","author":"P Sureau","year":"1989","journal-title":"Eur J Epidemiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0042-6822(89)90551-5","article-title":"Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors.","volume":"173","author":"C Prehaud","year":"1989","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0264-410X(98)00196-0","article-title":"Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells.","volume":"17","author":"S Sakamoto","year":"1999","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2005.04.007","article-title":"Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus.","volume":"108","author":"PK Gupta","year":"2005","journal-title":"Vet Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/nbt1295-1484","article-title":"Expression of the rabies virus glycoprotein in transgenic tomatoes.","volume":"13","author":"PB McGarvey","year":"1995","journal-title":"Biotechnology (N Y)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1016\/S0021-9258(19)50073-4","article-title":"N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression.","volume":"267","author":"SH Shakin-Eshleman","year":"1992","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0264-410X(93)90379-C","article-title":"Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.","volume":"11","author":"ZF Fu","year":"1993","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2005.06.009","article-title":"High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice.","volume":"119","author":"S Ashraf","year":"2005","journal-title":"J Biotechnol"},{"key":"ref49","first-page":"477","article-title":"Development of an edible rabies vaccine in maize using the Vnukovo strain.","volume":"131","author":"E Loza-Rubio","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults.","volume":"26","author":"A Lyons","year":"2008","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1093\/clinids\/10.Supplement_4.S803","article-title":"Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor).","volume":"10","author":"CE Rupprecht","year":"1988","journal-title":"Rev Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.iac.2006.11.001","article-title":"A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy.","volume":"27","author":"F Takaiwa","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","article-title":"Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.","volume":"20","author":"V Yusibov","year":"2002","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1995.tb44733.x","article-title":"Plasmid vectors as anti-viral vaccines.","volume":"772","author":"HC Ertl","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vim.1996.9.1","article-title":"Genetic immunization.","volume":"9","author":"HC Ertl","year":"1996","journal-title":"Viral Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0264-410X(97)88325-9","article-title":"Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection.","volume":"16","author":"DL Lodmell","year":"1998","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000053998","article-title":"DNA-based immunization against Lyssaviruses.","volume":"43","author":"P Perrin","year":"2000","journal-title":"Intervirology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1074-7613(95)80001-8","article-title":"Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.","volume":"2","author":"Z Xiang","year":"1995","journal-title":"Immunity"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0264-410X(99)00352-7","article-title":"DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).","volume":"18","author":"DL Lodmell","year":"2000","journal-title":"Vaccine"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.","volume":"24","author":"DL Lodmell","year":"2006","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus.","volume":"17","author":"JE Osorio","year":"1999","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination.","volume":"20","author":"DL Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetmic.2008.10.030","article-title":"Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein.","volume":"136","author":"S Saxena","year":"2009","journal-title":"Vet Microbiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1016\/j.vaccine.2008.09.083","article-title":"Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally.","volume":"26","author":"E Tesoro Cruz","year":"2008","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(02)00143-3","article-title":"Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.","volume":"20","author":"DL Lodmell","year":"2002","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges.","volume":"175","author":"JJ Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments.","volume":"17","author":"AM Bodles-Brakhop","year":"2009","journal-title":"Mol Ther"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref69","first-page":"467","article-title":"Canine adenovirus based rabies vaccines.","volume":"131","author":"N Tordo","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/vr.154.15.457","article-title":"Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.","volume":"154","author":"M Bohm","year":"2004","journal-title":"Vet Rec"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.","volume":"12","author":"Z Xiang","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus.","volume":"345","author":"CE Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","article-title":"Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.","volume":"25","author":"J Weyer","year":"2007","journal-title":"Vaccine"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.vaccine.2007.12.050","article-title":"A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs.","volume":"26","author":"Z Yuan","year":"2008","journal-title":"Vaccine"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods.","volume":"77","author":"JJ Rux","year":"2003","journal-title":"J Virol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/S0264-410X(00)00088-8","article-title":"Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.","volume":"18","author":"T Tims","year":"2000","journal-title":"Vaccine"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.4049\/jimmunol.162.11.6716","article-title":"Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.","volume":"162","author":"ZQ Xiang","year":"1999","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/viro.1996.0239","article-title":"A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.","volume":"219","author":"ZQ Xiang","year":"1996","journal-title":"Virology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.","volume":"110","author":"N Tatsis","year":"2007","journal-title":"Blood"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01317147","article-title":"Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.","volume":"123","author":"KM Charlton","year":"1992","journal-title":"Arch Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/161.1.27","article-title":"A recombinant human adenovirus vaccine against rabies.","volume":"161","author":"L Prevec","year":"1990","journal-title":"J Infect Dis"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.","volume":"81","author":"K McCoy","year":"2007","journal-title":"J Virol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.","volume":"76","author":"Z Xiang","year":"2002","journal-title":"J Virol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/aid.2008.0212","article-title":"Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.","volume":"25","author":"CD Harro","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/CVI.00173-07","article-title":"Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.","volume":"14","author":"MB Appaiahgari","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/JVI.71.5.3677-3683.1997","article-title":"The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.","volume":"71","author":"Y Wang","year":"1997","journal-title":"J Virol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.02616-07","article-title":"Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys.","volume":"82","author":"J Liu","year":"2008","journal-title":"J Virol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"e3790","DOI":"10.1371\/journal.pone.0003790","article-title":"rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.","volume":"3","author":"I Magalhaes","year":"2008","journal-title":"PLoS ONE"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.4049\/jimmunol.171.12.6774","article-title":"Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.","volume":"171","author":"AR Pinto","year":"2003","journal-title":"J Immunol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.mt.6300078","article-title":"A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.","volume":"15","author":"N Tatsis","year":"2007","journal-title":"Mol Ther"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors.","volume":"10","author":"N Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.4049\/jimmunol.171.8.4287","article-title":"Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.","volume":"171","author":"Z Xiang","year":"2003","journal-title":"J Immunol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ymthe.2006.03.027","article-title":"A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.","volume":"14","author":"D Zhou","year":"2006","journal-title":"Mol Ther"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2007.11.029","article-title":"Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.","volume":"26","author":"S Zhang","year":"2008","journal-title":"Vaccine"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.vaccine.2008.08.001","article-title":"Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.","volume":"26","author":"Y Liu","year":"2008","journal-title":"Vaccine"},{"key":"ref97","first-page":"69","article-title":"[The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].","author":"MM Shmarov","year":"2006","journal-title":"Zh Mikrobiol Epidemiol Immunobiol:"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:47:14Z","timestamp":1739360834000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000515"}},"subtitle":[],"editor":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,9,29]]},"references-count":97,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000515","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,29]]}}}